TrialBMC infectious diseases2003

Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients.

Jeffrey P Nadler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.